Ewing sarcoma cells depend upon EWS/FLI expression, lack additional ubiquitous genetic mutations, and show widespread epigenomic and transcriptomic alterations driven by the fusion protein [14–18]. This evidence concerns the gene FLII and Ewing sarcoma.